ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer ...
Abbott ABT, a global leader in healthcare solutions, recently achieved a significant milestone with the FDA approval of its cutting-edge Alinity h-series hematology system. This approval is poised to ...
ABBOTT PARK, Ill., Jan. 2, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced CE Mark for its Alinity h-series integrated system for hematology testing, joining the Alinity hq standalone ...
The Alinity h-series hematology system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced today that the FDA cleared its advanced Alinity h-series hematology system. FDA clearance enables ...
VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a non-exclusive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results